A detailed history of Bourne Lent Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 14,341 shares of JNJ stock, worth $2.1 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
14,341
Previous 14,341 -0.0%
Holding current value
$2.1 Million
Previous $2.25 Million 0.93%
% of portfolio
0.91%
Previous 0.91%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023

SELL
$154.35 - $166.11 $19,293 - $20,763
-125 Reduced 0.86%
14,341 $2.37 Million
Q4 2022

Jan 23, 2023

SELL
$160.2 - $179.79 $166,608 - $186,981
-1,040 Reduced 6.71%
14,466 $0
Q2 2022

Jul 27, 2022

SELL
$168.19 - $186.01 $33,638 - $37,202
-200 Reduced 1.27%
15,506 $2.75 Million
Q1 2022

Apr 26, 2022

SELL
$158.14 - $179.59 $7,906 - $8,979
-50 Reduced 0.32%
15,706 $2.78 Million
Q3 2021

Oct 20, 2021

SELL
$161.5 - $179.47 $16,150 - $17,947
-100 Reduced 0.63%
15,756 $2.55 Million
Q1 2021

Apr 23, 2021

BUY
$153.07 - $170.48 $9,184 - $10,228
60 Added 0.38%
15,856 $2.61 Million
Q4 2020

Jan 27, 2021

SELL
$137.11 - $157.38 $43,875 - $50,361
-320 Reduced 1.99%
15,796 $2.49 Million
Q1 2020

Apr 17, 2020

SELL
$111.14 - $153.99 $59,459 - $82,384
-535 Reduced 3.21%
16,116 $2.11 Million
Q3 2019

Oct 24, 2019

SELL
$126.95 - $142.14 $6,347 - $7,106
-50 Reduced 0.3%
16,651 $2.15 Million
Q4 2018

Jan 28, 2019

BUY
$122.84 - $147.84 $62,034 - $74,659
505 Added 3.12%
16,701 $2.16 Million
Q2 2018

Jul 25, 2018

SELL
$119.4 - $131.76 $41,790 - $46,116
-350 Reduced 2.12%
16,196 $1.97 Million
Q1 2018

Apr 20, 2018

SELL
$125.1 - $148.14 $52,542 - $62,218
-420 Reduced 2.48%
16,546 $2.12 Million
Q4 2017

Feb 06, 2018

BUY
$131.22 - $143.62 $125,971 - $137,875
960 Added 6.0%
16,966 $2.37 Million
Q3 2017

Oct 16, 2017

BUY
$129.47 - $135.38 $2.07 Million - $2.17 Million
16,006
16,006 $2.08 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bourne Lent Asset Management Inc Portfolio

Follow Bourne Lent Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourne Lent Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bourne Lent Asset Management Inc with notifications on news.